LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE)
- CAS No.
- 27244-64-0
- Chemical Name:
- LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE)
- Synonyms
- 6-Hydroxy-L-DOPA;Levodopa Related CoMpound A;(2S)-2-Amino-3-(2,4,5-trihydroxyphenyl)propanoic acid;Topa;Levodopa EP Impurity A;6-oh-dopa;Topaquinone;l-hydroxydopa;Hydroxy-L-dopa;l-6-hydroxydopa
- CBNumber:
- CB3501432
- Molecular Formula:
- C9H11NO5
- Molecular Weight:
- 213.19
- MDL Number:
- MOL File:
- 27244-64-0.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Levodopa Related Compound A Pharmaceutical Secondary Standard; Certified Reference Material | PHR2095 | 100mg | $691 |
| Levadopa Related Compound A | 1361010 | 50mg | $1390 |
| 6-Hydroxy-L-DOPA | TRC-H941725-25MG | 25mg | $295 |
| 6-Hydroxy-L-DOPA | TRC-H941725-250MG | 250mg | $2262 |
| 6-Hydroxy-L-DOPA | FH24378 | 10mg | $150 |
| More product size | |||
| Melting point | >190°C (dec.) |
|---|---|
| Boiling point | 515.2±38.0 °C(Predicted) |
| Density | 1.606±0.06 g/cm3(Predicted) |
| storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| solubility | Aqueous Acid (Slightly, Sonicated), Water (Slightly, Heated, Sonicated) |
| pka | 2.34±0.25(Predicted) |
| form | Solid |
| color | Brown to Black |
| Stability | Air Sensitive, Hygroscopic |
| Major Application | pharmaceutical (small molecule) |
| InChI | 1S/C9H11NO5/c10-5(9(14)15)1-4-2-7(12)8(13)3-6(4)11/h2-3,5,11-13H,1,10H2,(H,14,15)/t5-/m0/s1 |
| InChIKey | YLKRUSPZOTYMAT-YFKPBYRVSA-N |
| SMILES | [N+H3][C@@H](Cc1c(cc(c(c1)O)O)O)C(=O)[O-] |
| FDA UNII | 580PK2O48O |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315 |
| Precautionary statements | P264-P270-P280-P301+P312+P330-P332+P313-P501 |
| WGK Germany | WGK 3 |
| HS Code | 2922504500 |
| Storage Class | 11 - Combustible Solids |
| Hazard Classifications | Acute Tox. 4 Oral Skin Irrit. 2 |
LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE) price More Price(33)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | PHR2095 | Levodopa Related Compound A Pharmaceutical Secondary Standard; Certified Reference Material | 27244-64-0 | 100mg | $691 | 2026-04-30 | Buy |
| Sigma-Aldrich | 1361010 | Levadopa Related Compound A | 27244-64-0 | 50mg | $1390 | 2026-04-30 | Buy |
| TRC | TRC-H941725-25MG | 6-Hydroxy-L-DOPA | 27244-64-0 | 25mg | $295 | 2026-06-03 | Buy |
| TRC | TRC-H941725-250MG | 6-Hydroxy-L-DOPA | 27244-64-0 | 250mg | $2262 | 2026-06-03 | Buy |
| Biosynth | FH24378 | 6-Hydroxy-L-DOPA | 27244-64-0 | 10mg | $150 | 2026-06-04 | Buy |
LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE) Chemical Properties,Uses,Production
Uses
6-Hydroxy-L-DOPA (Levodopa EP Impurity A; Levodopa USP Related Compound A) is the 6-hydroxy derivative of the amino acid L-DOPA (D533751) with neurotoxic properties. Studies show that exogenously administered 6-Hydroxy-L-DOPA is biotransformed by amino acid decarboxylase to the highly potent and catecholamine-selective neurotoxin, 6-Hydroxydopamine. The treatment of 6-Hydroxy-L-DOPA in rats resulted in the stimulation of acetylcholinesterase.
Uses
6-Hydroxy-L-DOPA is the 6-hydroxy derivative of the amino acid L-DOPA (D533751) with neurotoxic properties. Studies show that exogenously administered 6-Hydroxy-L-DOPA is biotransformed by amino acid decarboxylase to the highly potent and catecholamine-selective neurotoxin, 6-Hydroxydopamine. The treatment of 6-Hydroxy-L-DOPA in rats resulted in the stimulation of acetylcholinesterase.
Definition
ChEBI: An L-alpha-amino acid that is L-dopa carrying an additional hydroxy substituent at position 6.
LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE) Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Sinco Pharmachem (ShenZhen) R&D Co., Ltd. | +undefined18603013401 | jack.lin@sincopharmachem.com | China | 9996 | 58 |
| Standardpharm Co. Ltd. | 86-714-3992388 | overseasales1@yongstandards.com | United States | 14332 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19936 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32466 | 58 |
| Finetech Industry Limited | +86-27-8746-5837 +8619945049750 | info@finetechnology-ind.com | China | 9539 | 58 |
| Nextpeptide Inc | +86-0571-81612335 +8613336028439 | sales@nextpeptide.com | China | 19908 | 58 |
| sgtlifesciences pvt ltd | +8617013299288 | dj@sgtlifesciences.com | China | 12373 | 58 |
| Guangzhou Tosun Pharmaceutical Limited | +86-18124244216 +86-18124244216 | info@upharm.cn | China | 998 | 58 |
| HANGZHOU LEAP CHEM CO., LTD. | +86-571-87711850 | market18@leapchem.com | China | 43333 | 58 |
| Aladdin Scientific | tp@aladdinsci.com | United States | 52923 | 58 |
27244-64-0(LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE))Related Search:
1of4





